1.Influence factors of untimely inoculation of measles vaccine among children of Enping
Xiaoli CEN ; Guangwen GUO ; Yiyan ZHEN
The Journal of Practical Medicine 2015;(18):3081-3084
Objective To know the influence factors of untimely inoculation of measles vaccine among children of Enping, so as to provide scientific evidence for infectious diseases control. Method Cluster sampling was used and children from 2 towns of Enping were surveyed for their status of measles immunization and other information related to the immunization. Results The results indicated that the coverage rate of measles vaccine (MV) was 92.03%, and the untimely coverage rate was 36.20%. There were no statistical difference between local children and migrant children , urban children and rural children , as well as male children and female children. The results of multi-variate Logistic analysis suggested that the main factors that could decrease the untimely coverage rate of MV were inoculation appointment (OR = 0.415), vaccination health education (OR=0.385), guardians′ education (OR = 0.393) and guardians′ EPI knowledge (OR=0.472). The main factors that could increase the untimely coverage rate of MV were children′s suffering from diseases (OR=2.376) and egg allergy (OR=2.476). Conclusion Greater attention should be paid on measles immunization among children of Enping, which should be noticed and dealt with by proper authorities.
2.Expert consensus on clinical application of 177Lu-prostate specific membrane antigen radio-ligand therapy in prostate cancer
Guobing LIU ; Weihai ZHUO ; Yushen GU ; Zhi YANG ; Yue CHEN ; Wei FAN ; Jianming GUO ; Jian TAN ; Xiaohua ZHU ; Li HUO ; Xiaoli LAN ; Biao LI ; Weibing MIAO ; Shaoli SONG ; Hao XU ; Rong TIAN ; Quanyong LUO ; Feng WANG ; Xuemei WANG ; Aimin YANG ; Dong DAI ; Zhiyong DENG ; Jinhua ZHAO ; Xiaoliang CHEN ; Yan FAN ; Zairong GAO ; Xingmin HAN ; Ningyi JIANG ; Anren KUANG ; Yansong LIN ; Fugeng LIU ; Cen LOU ; Xinhui SU ; Lijun TANG ; Hui WANG ; Xinlu WANG ; Fuzhou YANG ; Hui YANG ; Xinming ZHAO ; Bo YANG ; Xiaodong HUANG ; Jiliang CHEN ; Sijin LI ; Jing WANG ; Yaming LI ; Hongcheng SHI
Chinese Journal of Clinical Medicine 2024;31(5):844-850,封3
177Lu-prostate specific membrane antigen(PSMA)radio-ligand therapy has been approved abroad for advanced prostate cancer and has been in several clinical trials in China.Based on domestic clinical practice and experimental data and referred to international experience and viewpoints,the expert group forms a consensus on the clinical application of 177Lu-PSMA radio-ligand therapy in prostate cancer to guide clinical practice.